Skip to main content
LGVN logo

Longeveron Inc. (LGVN) Stock Price & Analysis

LGVNNASDAQHealthcareBiotechnology

$1.66Today:−$0.09 (−5.21%)1Y +203.33%

As of Nov 20, 2026 close

Market cap
$5.84M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.48$8.90
Volume (live)
-
Avg. volume (3M)
90.25K

Longeveron (LGVN) Stock Price Chart

Loading chart...

LGVN Key Statistics & Financial Metrics

Fundamental metrics, valuation ratios, and profitability indicators

Price & Trading Activity
Day's Range$1.64 - $1.83
52-Week High$8.90
52-Week Low$0.48
Open$1.83
Volume (last close)27.26K
Average Volume (3M)90.25K
Earnings & Profitability
Revenue (TTM)1.17M
Net Income (TTM)−22.39M
Free Cash Flow (TTM)−18.26M
EPS (TTM)−$8.05
Profit Margin−1921.72%
Operating Margin−2020.77%
Return on Equity (ROE)−475.33%
Debt to Equity0.12
Dividend Information
Annual Dividend$0.00
Dividend Yield0.00%
Size & Valuation
Market Cap5.84M
Shares Outstanding3.21M
Price to Sales (P/S)5.02
Price to Book (P/B)1.24
EV/EBITDA0.04
Technical Indicators
50-Day MA$2.44
200-Day MA$3.60
1-Year Change+203.33%

Source: Market prices and company fundamentals. Data as of Nov 20, 2026. Data sources and methodology

Compare LGVN with other stocks

Longeveron at a Glance

As of the Nov 20, 2026 close, Longeveron (LGVN) has a market capitalization of $5.84M. The stock trades at 5.0× sales. Over the trailing twelve months it lost $22.39M on revenue of $1.17M and burned $18.26M of free cash flow. Revenue fell 18.9% year over year.

As of its latest reported balance sheet, it holds $7.25M in cash and securities against $581.00K of debt, a net cash position of $6.66M.

Longeveron does not currently pay a dividend.

The share price is up 203.3% over the past year. At $1.66 (the Nov 20, 2026 close) it sits near the bottom of its 52-week range of $0.47 to $8.90, below its 200-day moving average of $3.60.

Frequently Asked Questions About Longeveron

What is the current stock price for LGVN?

As of the Nov 20, 2026 close, LGVN stock trades at $1.66. The 52-week range is $0.48–$8.90, with a day range of $1.64–$1.83.

What is the P/E ratio for LGVN?

Longeveron has no trailing P/E ratio because it reported a net loss over the last twelve months.

Does LGVN pay dividends?

Longeveron does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.

What is the market cap of LGVN?

As of the Nov 20, 2026 close, Longeveron's market capitalization is $5.3M, classifying it as a micro-cap company. Longeveron operates in the Healthcare sector within the Biotechnology industry.